Laminin β1 stimulates the Hippo-YAP1 pathway to advance the progression and lenvatinib resistance in hepatocellular carcinoma

Zhiliang Cai(Sun Yat-sen University), Fen Cao(Guangdong Academy of Medical Sciences), Xinyi Hu(Jinan University), Bo Li(Shanghai Jiao Tong University), Hao Chen(Nanjing University of Science and Technology), Bin Peng(Nanfang Hospital), Jinjin Li(Southern Medical University), Guobang Li(Guangdong Academy of Medical Sciences), Wanying Lin(Nanfang Hospital), Long Wu(University of Maryland, Baltimore), Qing Yang(Guangzhou University of Chinese Medicine)
International Journal of Biological Macromolecules
November 20, 2025
10.1016/j.ijbiomac.2025.149150
Cited by 1

Related Papers

The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
|Cell Reports|2018|1.3k
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
|JAMA|2021|821
Feedback control of morphogenesis in fungi by aromatic alcohols
|Genes & Development|2006|452
Removal of sulfamethoxazole and ciprofloxacin from aqueous solutions by graphene oxide
|Journal of Hazardous Materials|2014|436